GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ambalal Sarabhai Enterprises Ltd (BOM:500009) » Definitions » Debt-to-EBITDA

Ambalalrabhai Enterprises (BOM:500009) Debt-to-EBITDA : 1.33 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Ambalalrabhai Enterprises Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ambalalrabhai Enterprises's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹363 Mil. Ambalalrabhai Enterprises's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹98 Mil. Ambalalrabhai Enterprises's annualized EBITDA for the quarter that ended in Mar. 2024 was ₹348 Mil. Ambalalrabhai Enterprises's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 1.32.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Ambalalrabhai Enterprises's Debt-to-EBITDA or its related term are showing as below:

BOM:500009' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -8.91   Med: 1.86   Max: 5.24
Current: 2.9

During the past 13 years, the highest Debt-to-EBITDA Ratio of Ambalalrabhai Enterprises was 5.24. The lowest was -8.91. And the median was 1.86.

BOM:500009's Debt-to-EBITDA is ranked worse than
63.82% of 655 companies
in the Drug Manufacturers industry
Industry Median: 1.67 vs BOM:500009: 2.90

Ambalalrabhai Enterprises Debt-to-EBITDA Historical Data

The historical data trend for Ambalalrabhai Enterprises's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ambalalrabhai Enterprises Debt-to-EBITDA Chart

Ambalalrabhai Enterprises Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.49 0.74 0.46 2.23 2.90

Ambalalrabhai Enterprises Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.24 - 2.88 - 1.33

Competitive Comparison of Ambalalrabhai Enterprises's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Ambalalrabhai Enterprises's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ambalalrabhai Enterprises's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ambalalrabhai Enterprises's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Ambalalrabhai Enterprises's Debt-to-EBITDA falls into.



Ambalalrabhai Enterprises Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Ambalalrabhai Enterprises's Debt-to-EBITDA for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(363.399 + 97.727) / 159.281
=2.90

Ambalalrabhai Enterprises's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(363.399 + 97.727) / 348.128
=1.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


Ambalalrabhai Enterprises  (BOM:500009) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Ambalalrabhai Enterprises Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Ambalalrabhai Enterprises's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Ambalalrabhai Enterprises (BOM:500009) Business Description

Traded in Other Exchanges
N/A
Address
Mirzapur Road, Shanti Sadan, Ahmedabad, GJ, IND, 380001
Ambalal Sarabhai Enterprises Ltd is an India-based company engaged in the manufacturing and marketing of Drugs and Formulation. Its operating segments are Pharmaceutical Products. It serves domestic as well as international markets.

Ambalalrabhai Enterprises (BOM:500009) Headlines

No Headlines